Table 1.
Approaches | Mechanisms |
---|---|
Addition of carbon source with antibiotics (Allison et al., 2011; Orman & Brynildsen, 2013; Taber et al., 1987) | Resuscitates persisters and allows cells to increase intake of conventional antibiotics |
Addition of efflux pump inhibitors with antibiotics (phenylalanine arginyl β-naphthylamide (PAbN) or 1-(1-Naphthylmethyl) piperazine (NMP) (Pu et al., 2016) | Blocks efflux of conventional antibiotics |
Acyldepsipeptide (ADEP 4 (Carney et al., 2014; Conlon et al., 2013; Lee et al., 2010; Li et al., 2010) | Activates ClpP to be a non-specific protease and kills persister cells by uncontrollable protein degradation |
Defensins, cathelicidins (Defraine et al., 2018; Mohammad et al., 2015) HT61 (Hu et al., 2010; Hubbard et al., 2017a) |
Disrupts bacterial cell membrane in a growth-independent manner |
KCN (Respiration inhibitor) (Orman & Brynildsen, 2015) | Impairs stationary phase respiratory activity and prevents self-digestion of endogenous proteins and RNA, which yields bacteria that are more capable of translation, replication and concomitantly cell death when exposed to antibiotics |
M64 (MvfR inhibitor) (Allegretta et al., 2017; Starkey et al., 2014; Vieira et al., 2022) | Targets quorum sensing regulator and inhibits persister formation |
Relacin (Wexselblatt et al., 2012) | Affects entry into stationary phase in several Gram-positive bacteria, leading reduction in cell survival |
Cis-2-decenoic acid (Marques et al., 2014) | Increases metabolic activity and reverts persisters into an antibiotic-susceptible state |